Thalassemia Mutations in Lower Northern Part of Thailand

Authors

  • Chonnanit Choopayak Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
  • Saisiri Mirasenaa Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
  • Chanasorn Poodendaen Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
  • Arunya Jiraviriyakul Department of Medical Technology, Faculty of Allied Health Science, Naresuan University, Phitsanulok 65000, Thailand.
  • Kanok-on Sangarun Department of Medical Technology, Faculty of Allied Health Science, Naresuan University, Phitsanulok 65000, Thailand.
  • Dawan Shimbhu Department of Medical Technology, Faculty of Allied Health Science, Naresuan University, Phitsanulok 65000, Thailand.

Keywords:

thalassemia carrier, osmotic fragility test, dichlorophenol-indophenol test, polymerase chain reaction, hemoglobin E, Southest Asian type

Abstract

Thalassemia is one of the most serious genetically transmitted diseases creating health problems in many parts of Thailand including the lower North.  Therefore, screening test for both alpha and beta globin gene mutations will be useful for a program of prevention and control of thalassemic disease.  The screening test includes osmotic fragility (OF) test, dichlorophenol-indophenol (DCIP) test, quantitation of HbA2, HbE screening and PCR analysis. Five hundred blood samples were collected from a population living in Uttaradit, Phetchabun, and Phitsanulok.  The results showed a high frequency of thalassemic disorders (40.4%) in this population and one major thalassemic disease (compound heterozygous HbE/β-thal). Among them, heterozygous Hemoglobin E (HbE trait) was found to be  the most common in 133 subjects (26.6%) and alpha thalassemia 1, Southeast Asian type carriers (α-thal 1, SEA) (heterozygous α-thalassemia 1) in 39 subjects (7.8%). Homozygous HbE (Homo HbE) was found in 19 subjects (3.8%), whereas heterozygous beta thalassemia (β-thal trait) was found in 11 subjects (2.2%).  In addition to HbE/β-thal, 6 more subjects with compound heterozygote were also found, 4 of  α-thal 1/HbE, and 2 of  α-thal 1/ β-thal.  By using PCR, HbE mutation was confirmed and  -thal traits were analyzed for 5 different mutations. Among 11 β-thal traits, mutation in codon 41/42 (4 bp deletion) was the most frequent in 9 samples (1.8%), codon 17 (A-T) mutation was detected in one sample (0.2%), IVS-1-5 (G-C) was detected in one sample (0.2%), whereas mutation in codon 71/72 (+A) and IVS-1-1 (G-T) was not detected. The data will be useful for setting a strategy for prevention and control of thalassemia in this area.

References

Chan, V., Chan, T. K., Chebab, F. F., & Todd, D. (1987). Distribution of β-thalassemia mutations in south China and their association with haplotypes. American Journal of Human Genetics, 41, 678-685.

Chamrasratanokorn, T., Sanguansermsri, T., & Punyakaew, A. (1998). Two minutes osmotic fragility test (2 MIN OF) and severe thalassemia trait screening. Bullitin of the Chiang Mai Association Medical Sciences, 31, 28.

Choopayak, C., Limmonkon, A., Suyasunanont, U., & Poungbangpho, S. (2003). PCR detection of α-thalassemia 1 (Southeast Asian type) carriers in the south northern Thailand. Naresuan University Journal, 11, 29-36.

Flazt, G., Pik, C., & Sringam, S. (1965). Hemoglobinopathies in Thailand. II. Incidence and distribution of evaluations of hemoglobin A2 and hemoglobin F: a survey of 2790 people. The British Journal of Hematology, 11, 227-236.

Fucharoen, S., Fucharoen, G., Sriroongrung, W., Laosombat, V., Jetsrisuparb,A., Prasatkaew, S., et al. (1989). Molecular basis of β-thalassemia in Thailand: analysis of β-thalassemia mutations using the polymerase chain reaction. Human Genetics, 84, 41-46.

Fucharoen, S., Fucharoen, G.., Ratanasiri, T., & Jetsrisuparb, A. (1995). A simple non-radioactive method for detecting β-thalassemia/HbE disease: application to prenatal diagnosis. The Southeast Asian Journal of Tropical Medicine and Public Health, 26(Suppl. 1), 278-281.

Fucharoen, G.., Fucharoen, S., Wanhakit, C., & Srithong, W. (1995). Molecular basis of alpha (0)-thalassemia in northeast of Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 26(Suppl. 1), 249-251.

Fucharoen, S., Winichagoon, P. (1987). Hemoglobinopathies in Southeast Asia. Hemoglobin, 11, 65-88.

Fucharoen, S., Winichagoon, P. (1992). Thalassemia in Southeast Asia: problems and strategy for prevention and control. The Southeast Asian Journal of Tropical Medicine and Public Health, 23, 647-655.

Fukumaki, Y., Fucharoen, S., Fucharoen, G., Okamoto, N., Ichinose, M., Jetsrisuparb, A., et al. (1992). Molecular heterogeneity of beta-thalassemia in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 23(Suppl. 2),14-21.

Greenberg, P. L., Gordeuk., V., Issaragrisil, S., & Siritanaratkul, N. (2001). Major hematologic diseases in the developing world-new aspects of diagnosis and management of thalassemia, malaria anemia, and acute leukemia. Hematology, 1, 479.

Indaratna, K. (1997). Screening for thalassemia: An economic viewpoint. The Southeast Asian Journal of Tropical Medicine and Public Health, 28(Suppl. 3), 75-81.

Kazazian, H. H., Jr., Dowling, C. E., Waber, P. G., & Huang, S. (1986). The spectrum of β-thalassemia genes in China and Southeast Asia. Blood, 68, 964-966.

Kitsirisakul, B., Steger, H. F., & Sanguansermsri, T. (1996). Frequency of alpha-thalassemia of the Southeast Asian-type among pregnant women in northern Thailand determined by PCR technique. The Southeast Asian Journal of Tropical Medicine and Public Health, 27, 362-363.

Laig, M., Sanguansermsri, T., Wiangnon, S., & Hundrieser, J. (1989). The spectrum of β-thalassemia mutations in northern and northeastern Thaialnd. Humam Genetics, 84, 47-50.

Laosombat, V., Fucharoen, S., Panich, V., Fucharoen, G., Wongchanchailert, M., Sriroongrueng, W., et al. (1992). Molecular basis of β-thalassemia in the south of Thailand. American Journal of Hematology, 41, 194-198.

Laosombat, V., Wongchanchailert, M., Sattayasevana, B., & Wiriyasateinkul, A. (2001). Clinical and hematologic features of beta0-thalassemia (frameshift 41/42 mutation) in Thai patients. Hematologica, 86, 138-141.

Lemmens-Zygulska, M., Eigel, A., Helbig, B., & Sanguansermsri, T., (1996). Prevalence of alpha-thalassemias in northern Thailand. Human Genetics, 98, 345-347.

Na-Nakorn, S., Minnich, V., Chernoff, A. I., & Quaggui-Puag, S. (1956). Studies on hemoglobin E. II: the incidence of hemoglobin E in Thailand. Journal of Laboratory Clinical Medicine, 47, 490-498.

Na-Nakorn, S., & Wasi, P. (1978). The distribution of hemoglobin E: hemoglobin E triangle in Southeast Asia. Journal of the Medical Library Association Thai, 61, 65.

Nopparatana, C. (1998). Molecular diagnosis of thalassemias. Songklanakarin Medical Journal, 16, 145-149.

Nopparatana, C., Panich, V., Saechan, V., Sriroongrueng, V., Nopparatana, C., Rungjeadpha, J., et al. (1995). The spectrum of beta-thalassemia mutations in southern Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 26(Suppl. 1), 229-234.

Pansatiankul , B., & Saisorn, S. (2003). A community-based thalassemia prevention and control model in northern Thailand. Journal of the Medical Library Association Thai, 86(Suppl. 3), S576-S582.

Panyasai, S., Sringam, P., Fucharoen, G., & Sanchaisuriya, K. (2002). A simplified screening for α-thalassemia 1 (SEA type) using a combination of a modified osmotic fragility test and a direct PCR on whole blood cell lysates. Acta Haematologica, 108,74-78.

Paritpokee, N., Suwansaksri, J., Wiwanitkit, V., & Siritantikorn, A. (1999). Screening tests for inherited hemoglobin disorders in pregnancies. Chulalongkorn Medical Journal, 43, 645-653.

Pravatmuang, P., Kumnerdsiri, B., & Saiyen, P. (1988). Prevalence of haemoglobinopathies and anemia in Phetchaburi, Thailand. Hemoglobin, 12, 645-652.

Pravatmuang, P., Tiloklurs, M., Suannum, M., & Chaipat, C. (1995). Phitsanulok population: the highest incidence of hemoglobin E in the northern provinces of Thailand and PND counseling. The Southeast Asian Journal of Tropical Medicine and Public Health, 26(Suppl. 1), 266-270.

Sanguansermsri, T., Steger, H. F., Sirivatanapa, P., & Wanapirak, C. (1998). Prevention and control of severe thalassemia syndrome: Chiang Mai strategy. Thai Journal of Hematology and Transfusion Medicine, 8, 207-214.

Sanguansermsri, T., Sangkapreecha, C., & Steger, H. F. (1998). HbE screening test. Thai Journal of Hematology and Transfusion Medicine, 8, 215-221.

Sanguansermsri, T., Thanarattanakorn, P., Steger, H. F., Tongsong, T., Chanpraparp, P., Wanpirak, C., et al. (2001). Prenatal diagnosis of beta-thalassemia major by high-performance liquid chromatography analysis in fetal blood samples. Hemoglobin, 25, 19-27.

Sirichotoyakul, S., Saetung, R., Sanguansermsri, T. (2003). Analysis of β-thalassemia mutations in northern Thaialnd using an automated fluorescence DNA sequencing technique. Hemoglobin, 27, 89-95.

Sutcharitchan, P., Saiki, R., Fucharoen, S., & Winichagoon, P. (1995). Reverse dot-blot detection of Thai β-thalassemia mutations. The British Journal of Hematology, 90, 809-816.

Tanphaichitr, V. (1999, May). Current situation of thalassemia in Thailand. Paper presented at the 7th international conference on Thalassemia and the Haemoglobinopathies 1999, Thailand.

Thein, S. L., Winichagoon, P., Hesketh, C., Best, S., Fucharoen, S., Wasi, P., et al. (1990). The molecular basis of β-thalassemia in Thailand: application to prenatal diagnosis. American Journal of Human Genetics, 47, 369-375.

Wasi, P., Pootrakul, S., Pootrakul, P., & Pravatmuang, P. (1980). Thalassemia in Thailand. The Annals of the New York Academy of Sciences, 344, 352-363.

Winichagoon, P., Fucharoen, S., Kanokpongsakdi, S., & Fukumaki, Y. (1995). Detection of α-thalassemia 1 (Southeast Asian type) by polymerase chain reaction: its application to Thai population. Clinical Genetics, 47, 318-320.

Winichagoon, P., Fucharoen, S., & Wasi, P. (1992). The molecular basis of α-thalassemia in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 23(Suppl. 2), 7-13.

Wiwanitkit, V., Suwansaksri, J., & Paritpokee, N. (2002). Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women. Clinical Laboratory, 48, 525-528.

Downloads

Published

2005-10-05

Issue

Section

Research Articles